Company / Capital Expenditures
DaVita Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$575.9M
FY2025
5-year range
$555.4M / $766.5M
FY2021-FY2025
Trend
+3.7%
vs FY2024
Sector context
#18 of 151
Health Care
What the data says
DaVita's capital expenditures of $576M is higher than 88% of companies in the Health Care sector (FY2025). Capital Expenditures returned to growth in FY2025 after 4 years of decline, reaching $576M.
Based on SEC 10-K filings.
$576M in FY2025 with a 5-year CAGR of -10.2%. Top quartile in the Health Care sector.
Declined from $641M to $576M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -5.1%
- 5-Year CAGR
- -10.2%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 151This company $575.9M Sector average $271.7M
▼
+112.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -10.2%, indicating a declining trend.
- In FY2025, capital expenditures increased 3.7% year-over-year.
- Ranks #18 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $575.9M | +3.7% |
| FY2024 | $555.4M | -13.4% |
| FY2023 | $641.5M | -4.9% |
| FY2022 | $674.5M | -12.0% |
| FY2021 | $766.5M | -22.3% |
| FY2020 | $987.1M | +9.0% |
| FY2019 | $905.3M | +9.2% |
| FY2018 | $829.1M | -8.4% |
| FY2017 | $905.3M | +9.2% |
| FY2016 | $829.1M | +17.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026